Source: Clinical and Experimental Pharmacology and Physiology. Unidade: FM
Subjects: INFARTO DO MIOCÁRDIO (PATOLOGIA), RATOS, MODELOS ANIMAIS DE DOENÇAS, MORFOMETRIA, INFLAMAÇÃO, MIOCÁRDIO
ABNT
KOIKE, Marcia Kiyomi e FRIMM, Clovis de Carvalho e HIGUCHI, Maria de Lourdes. Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats. Clinical and Experimental Pharmacology and Physiology, v. 32, p. 1131-1136, 2005Tradução . . Disponível em: https://doi.org/10.1111/j.1440-1681.2005.04309.x. Acesso em: 17 nov. 2024.APA
Koike, M. K., Frimm, C. de C., & Higuchi, M. de L. (2005). Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats. Clinical and Experimental Pharmacology and Physiology, 32, 1131-1136. doi:10.1111/j.1440-1681.2005.04309.xNLM
Koike MK, Frimm C de C, Higuchi M de L. Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats [Internet]. Clinical and Experimental Pharmacology and Physiology. 2005 ; 32 1131-1136.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/j.1440-1681.2005.04309.xVancouver
Koike MK, Frimm C de C, Higuchi M de L. Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats [Internet]. Clinical and Experimental Pharmacology and Physiology. 2005 ; 32 1131-1136.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/j.1440-1681.2005.04309.x